hu.MAP 2.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: HuMAP2_04642
Confidence: Very High  
ProteinsGenename | Protein Name | Links |
---|---|---|
SDHAF2 | Succinate dehydrogenase assembly factor 2, mitochondrial (SDH assembly factor 2) (SDHAF2) | UniProt   NCBI |
SDHB | Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip) | UniProt   NCBI |
SDHA | Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) | UniProt   NCBI |
SDHAF4 | Succinate dehydrogenase assembly factor 4, mitochondrial (SDH assembly factor 4) (SDHAF4) | UniProt   NCBI |
Enrichments
Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
---|---|---|---|---|
  HP:0003639 | 5.03496710668e-07 | 0.75 | SDHB SDHAF2 SDHA | Elevated urinary epinephrine |
  HP:0000740 | 5.03496710668e-07 | 0.75 | SDHB SDHAF2 SDHA | Episodic paroxysmal anxiety |
  HP:0010532 | 5.03496710668e-07 | 0.75 | SDHB SDHAF2 SDHA | Paroxysmal vertigo |
  HP:0008629 | 5.03496710668e-07 | 0.75 | SDHB SDHAF2 SDHA | Pulsatile tinnitus |
  HP:0002864 | 5.03496710668e-07 | 0.75 | SDHB SDHAF2 SDHA | Paraganglioma of head and neck |
  HP:0006737 | 5.03496710668e-07 | 0.75 | SDHB SDHAF2 SDHA | Extraadrenal pheochromocytoma |
  HP:0012222 | 6.71295121779e-07 | 0.75 | SDHB SDHAF2 SDHA | Arachnoid hemangiomatosis |
  HP:0006748 | 6.71295121779e-07 | 0.75 | SDHB SDHAF2 SDHA | Adrenal pheochromocytoma |
  HP:0001095 | 6.71295121779e-07 | 0.75 | SDHB SDHAF2 SDHA | Hypertensive retinopathy |
  HP:0003574 | 6.71295121779e-07 | 0.75 | SDHB SDHAF2 SDHA | Positive regitine blocking test |
  HP:0100642 | 6.71295121779e-07 | 0.75 | SDHB SDHAF2 SDHA | Neoplasm of the adrenal medulla |
  HP:0003345 | 6.71295121779e-07 | 0.75 | SDHB SDHAF2 SDHA | Elevated urinary norepinephrine |
  HP:0009711 | 6.71295121779e-07 | 0.75 | SDHB SDHAF2 SDHA | Retinal capillary hemangioma |
  HP:0002331 | 8.72639684801e-07 | 0.75 | SDHB SDHAF2 SDHA | Recurrent paroxysmal headache |
  HP:0011979 | 8.72639684801e-07 | 0.75 | SDHB SDHAF2 SDHA | Elevated urinary dopamine |
  HP:0002640 | 8.72639684801e-07 | 0.75 | SDHB SDHAF2 SDHA | Hypertension associated with pheochromocytoma |
  HP:0003528 | 1.11057635982e-06 | 0.75 | SDHB SDHAF2 SDHA | Elevated calcitonin |
  HP:0010797 | 1.11057635982e-06 | 0.75 | SDHB SDHAF2 SDHA | Hemangioblastoma |
  HP:0002668 | 1.38815049192e-06 | 0.75 | SDHB SDHAF2 SDHA | Paraganglioma |
  HP:0002666 | 1.38815049192e-06 | 0.75 | SDHB SDHAF2 SDHA | Pheochromocytoma |
  GO:0005749 | 1.45302402969e-06 | 0.75 | SDHB SDHAF4 SDHA | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) |
  GO:0045283 | 1.45302402969e-06 | 0.75 | SDHB SDHAF4 SDHA | fumarate reductase complex |
  GO:0045281 | 1.45302402969e-06 | 0.75 | SDHB SDHAF4 SDHA | succinate dehydrogenase complex |
  GO:0045273 | 1.45302402969e-06 | 0.75 | SDHB SDHAF4 SDHA | respiratory chain complex II |
  GO:0045257 | 1.45302402969e-06 | 0.75 | SDHB SDHAF4 SDHA | succinate dehydrogenase complex (ubiquinone) |
  HP:0031284 | 2.07438943256e-06 | 0.75 | SDHB SDHAF2 SDHA | Flushing |
  HP:0001069 | 2.07438943256e-06 | 0.75 | SDHB SDHAF2 SDHA | Episodic hyperhidrosis |
  HP:0009594 | 2.07438943256e-06 | 0.75 | SDHB SDHAF2 SDHA | Retinal hamartoma |
  HP:0011703 | 2.48914185619e-06 | 0.75 | SDHB SDHAF2 SDHA | Sinus tachycardia |
  HP:0011281 | 3.47712703514e-06 | 0.75 | SDHB SDHAF2 SDHA | Abnormality of urine catecholamine concentration |
  HP:0011976 | 3.47712703514e-06 | 0.75 | SDHB SDHAF2 SDHA | Elevated urinary catecholamines |
  HP:0010568 | 4.69669804797e-06 | 0.75 | SDHB SDHAF2 SDHA | Hamartoma of the eye |
  HP:0001293 | 4.69669804797e-06 | 0.75 | SDHB SDHAF2 SDHA | Cranial nerve compression |
  HP:0030670 | 4.69669804797e-06 | 0.75 | SDHB SDHAF2 SDHA | Hamartoma of the orbital region |
  HP:0025269 | 8.91842784173e-06 | 0.75 | SDHB SDHAF2 SDHA | Panic attack |
  HP:0100634 | 8.91842784173e-06 | 0.75 | SDHB SDHAF2 SDHA | Neuroendocrine neoplasm |
  HP:0031801 | 9.98813548614e-06 | 0.75 | SDHB SDHAF2 SDHA | Vocal cord dysfunction |
  HP:0002574 | 9.98813548614e-06 | 0.75 | SDHB SDHAF2 SDHA | Episodic abdominal pain |
  HP:0001605 | 9.98813548614e-06 | 0.75 | SDHB SDHAF2 SDHA | Vocal cord paralysis |
  HP:0032148 | 9.98813548614e-06 | 0.75 | SDHB SDHAF2 SDHA | Episodic pain |
  HP:0100631 | 1.11400508422e-05 | 0.75 | SDHB SDHAF2 SDHA | Neoplasm of the adrenal gland |
  HP:0100530 | 1.23772100297e-05 | 0.75 | SDHB SDHAF2 SDHA | Abnormal calcium-phosphate regulating hormone level |
  HP:0000360 | 1.82389859666e-05 | 0.75 | SDHB SDHAF2 SDHA | Tinnitus |
  HP:0000526 | 1.82389859666e-05 | 0.75 | SDHB SDHAF2 SDHA | Aniridia |
  HP:0100012 | 2.17602308369e-05 | 0.75 | SDHB SDHAF2 SDHA | Neoplasm of the eye |
  HP:0003072 | 3.2479768623e-05 | 0.75 | SDHB SDHAF2 SDHA | Hypercalcemia |
  HP:0100007 | 3.2479768623e-05 | 0.75 | SDHB SDHAF2 SDHA | Neoplasm of the peripheral nervous system |
  HP:0001342 | 3.49764472726e-05 | 0.75 | SDHB SDHAF2 SDHA | Cerebral hemorrhage |
  HP:0011702 | 4.62400081268e-05 | 0.75 | SDHB SDHAF2 SDHA | Abnormal electrophysiology of sinoatrial node origin |
  HP:0002018 | 4.939024284e-05 | 0.75 | SDHB SDHAF2 SDHA | Nausea |
  HP:0000096 | 6.34193111797e-05 | 0.75 | SDHB SDHAF2 SDHA | Glomerulosclerosis |
  HP:0005584 | 6.34193111797e-05 | 0.75 | SDHB SDHAF2 SDHA | Renal cell carcinoma |
  HP:0030074 | 6.81856710606e-05 | 0.5 | SDHB SDHAF2 | Chemodectoma |
  HP:0003001 | 6.81856710606e-05 | 0.5 | SDHB SDHAF2 | Glomus jugular tumor |
  HP:0001962 | 8.4395655229e-05 | 0.75 | SDHB SDHAF2 SDHA | Palpitations |
  HP:0010566 | 0.000120860429779 | 0.75 | SDHB SDHAF2 SDHA | Hamartoma |
  HP:0100749 | 0.000126797979354 | 0.75 | SDHB SDHAF2 SDHA | Chest pain |
  HP:0025191 | 0.000136359131835 | 0.5 | SDHB SDHA | Segmental myoclonic seizures |
  HP:0011732 | 0.00015941280611 | 0.75 | SDHB SDHAF2 SDHA | Abnormality of adrenal morphology |
  HP:0100835 | 0.000173880942073 | 0.75 | SDHB SDHAF2 SDHA | Benign neoplasm of the central nervous system |
  HP:0001618 | 0.000181431813171 | 0.75 | SDHB SDHAF2 SDHA | Dysphonia |
  HP:0040196 | 0.000227244870274 | 0.5 | SDHB SDHA | Mild microcephaly |
  WP:WP78 | 0.000228185108581 | 0.5 | SDHB SDHA | TCA Cycle (aka Krebs or citric acid cycle) |
  HP:0002321 | 0.000279357285882 | 0.75 | SDHB SDHAF2 SDHA | Vertigo |
  HP:0002170 | 0.000333559712077 | 0.75 | SDHB SDHAF2 SDHA | Intracranial hemorrhage |
  HP:0009726 | 0.000333559712077 | 0.75 | SDHB SDHAF2 SDHA | Renal neoplasm |
  HP:0003756 | 0.000340836782771 | 0.5 | SDHB SDHA | Skeletal myopathy |
  HP:0012817 | 0.000340836782771 | 0.5 | SDHB SDHA | Noncompaction cardiomyopathy |
  HP:0004363 | 0.000369216596452 | 0.75 | SDHB SDHAF2 SDHA | Abnormal circulating calcium concentration |
  HP:0100568 | 0.0004073240164 | 0.75 | SDHB SDHAF2 SDHA | Neoplasm of the endocrine system |
  GO:0045333 | 0.000419088323416 | 1.0 | SDHB SDHAF4 SDHAF2 SDHA | cellular respiration |
  HP:0008053 | 0.000434130330519 | 0.75 | SDHB SDHAF2 SDHA | Aplasia/Hypoplasia of the iris |
  HP:0008055 | 0.000434130330519 | 0.75 | SDHB SDHAF2 SDHA | Aplasia/Hypoplasia affecting the uvea |
  HP:0008062 | 0.000491214063164 | 0.75 | SDHB SDHAF2 SDHA | Aplasia/Hypoplasia affecting the anterior segment of the eye |
  HP:0010927 | 0.000491214063164 | 0.75 | SDHB SDHAF2 SDHA | Abnormal blood inorganic cation concentration |
  HP:0010786 | 0.000553085565358 | 0.75 | SDHB SDHAF2 SDHA | Urinary tract neoplasm |
  HP:0001751 | 0.000569323965231 | 0.75 | SDHB SDHAF2 SDHA | Vestibular dysfunction |
  HP:0012614 | 0.000585876554513 | 0.75 | SDHB SDHAF2 SDHA | Abnormal urine cytology |
  HP:0000790 | 0.000585876554513 | 0.75 | SDHB SDHAF2 SDHA | Hematuria |
  HP:0003470 | 0.000585876554513 | 0.75 | SDHB SDHAF2 SDHA | Paralysis |
  HP:0001028 | 0.000585876554513 | 0.75 | SDHB SDHAF2 SDHA | Hemangioma |
  HP:0000975 | 0.000619936255745 | 0.75 | SDHB SDHAF2 SDHA | Hyperhidrosis |
  HP:0100742 | 0.000619936255745 | 0.75 | SDHB SDHAF2 SDHA | Vascular neoplasm |
  HP:0007083 | 0.000636114718594 | 0.5 | SDHB SDHA | Hyperactive patellar reflex |
  HP:0100006 | 0.000710792961621 | 0.75 | SDHB SDHAF2 SDHA | Neoplasm of the central nervous system |
  HP:0000980 | 0.000810101694231 | 0.75 | SDHB SDHAF2 SDHA | Pallor |
  KEGG:00020 | 0.000811520562786 | 0.5 | SDHB SDHA | Citrate cycle (TCA cycle) |
  HP:0007272 | 0.000817788537784 | 0.5 | SDHB SDHA | Progressive psychomotor deterioration |
  HP:0000095 | 0.000964043113657 | 0.75 | SDHB SDHAF2 SDHA | Abnormality of renal glomerulus morphology |
  HP:0031263 | 0.000964043113657 | 0.75 | SDHB SDHAF2 SDHA | Abnormal renal corpuscle morphology |
  HP:0011166 | 0.00102214412276 | 0.5 | SDHB SDHA | Focal myoclonic seizures |
  HP:0000093 | 0.00124335446085 | 0.75 | SDHB SDHAF2 SDHA | Proteinuria |
  HP:0011343 | 0.00124917537299 | 0.5 | SDHB SDHA | Moderate global developmental delay |
  HP:0004375 | 0.00138633858335 | 0.75 | SDHB SDHAF2 SDHA | Neoplasm of the nervous system |
  GO:0006099 | 0.00147288799354 | 0.75 | SDHB SDHAF2 SDHA | tricarboxylic acid cycle |
  HP:0020129 | 0.00147716207969 | 0.75 | SDHB SDHAF2 SDHA | Abnormal urine protein level |
  HP:0007350 | 0.00149887618857 | 0.5 | SDHB SDHA | Hyperreflexia in upper limbs |
  HP:0011035 | 0.00157185823159 | 0.75 | SDHB SDHAF2 SDHA | Abnormal renal cortex morphology |
  GO:0015980 | 0.00157802566628 | 1.0 | SDHB SDHAF4 SDHAF2 SDHA | energy derivation by oxidation of organic compounds |
  HP:0000834 | 0.00163717999905 | 0.75 | SDHB SDHAF2 SDHA | Abnormality of the adrenal glands |
  HP:0007379 | 0.00170428221874 | 0.75 | SDHB SDHAF2 SDHA | Neoplasm of the genitourinary tract |
  HP:0007550 | 0.00170428221874 | 0.75 | SDHB SDHAF2 SDHA | Hypohidrosis or hyperhidrosis |
  HP:0100833 | 0.00177124047018 | 0.5 | SDHB SDHA | Neoplasm of the small intestine |
  HP:0002333 | 0.00177124047018 | 0.5 | SDHB SDHA | Motor deterioration |
  HP:0100723 | 0.00177124047018 | 0.5 | SDHB SDHA | Gastrointestinal stroma tumor |
  HP:0025276 | 0.00191650845368 | 0.75 | SDHB SDHAF2 SDHA | Abnormality of skin adnexa physiology |
  REAC:R-HSA-71403 | 0.00210807296175 | 0.5 | SDHB SDHA | Citric acid cycle (TCA cycle) |
  HP:0008046 | 0.00214561105026 | 0.75 | SDHB SDHAF2 SDHA | Abnormal retinal vascular morphology |
  HP:0001635 | 0.00226669049436 | 0.75 | SDHB SDHAF2 SDHA | Congestive heart failure |
  HP:0002474 | 0.00238393503741 | 0.5 | SDHB SDHA | Expressive language delay |
  HP:0006895 | 0.00238393503741 | 0.5 | SDHB SDHA | Lower limb hypertonia |
  HP:0012575 | 0.0023922283415 | 0.75 | SDHB SDHAF2 SDHA | Abnormal nephron morphology |
  HP:0010929 | 0.00270293563817 | 0.75 | SDHB SDHAF2 SDHA | Abnormal blood cation concentration |
  GO:0000104 | 0.00270494046827 | 0.5 | SDHA SDHAF4 | succinate dehydrogenase activity |
  GO:0008177 | 0.00270494046827 | 0.5 | SDHA SDHAF4 | succinate dehydrogenase (ubiquinone) activity |
  HP:0100751 | 0.00272425312749 | 0.5 | SDHB SDHA | Esophageal neoplasm |
  HP:0012288 | 0.00347280043641 | 0.5 | SDHB SDHA | Neoplasm of head and neck |
  HP:0003111 | 0.00385156742772 | 0.75 | SDHB SDHAF2 SDHA | Abnormal blood ion concentration |
  HP:0002027 | 0.00433834919234 | 0.75 | SDHB SDHAF2 SDHA | Abdominal pain |
  HP:0007700 | 0.00446611555555 | 0.75 | SDHB SDHAF2 SDHA | Ocular anterior segment dysgenesis |
  HP:0001291 | 0.00466241342294 | 0.75 | SDHB SDHAF2 SDHA | Abnormal cranial nerve morphology |
  HP:0011029 | 0.00486435946898 | 0.75 | SDHB SDHAF2 SDHA | Internal hemorrhage |
  HP:0100659 | 0.00528551172659 | 0.75 | SDHB SDHAF2 SDHA | Abnormality of the cerebral vasculature |
  HP:0001824 | 0.00543109559899 | 0.75 | SDHB SDHAF2 SDHA | Weight loss |
  HP:0011028 | 0.00557931827591 | 0.75 | SDHB SDHAF2 SDHA | Abnormality of blood circulation |
  HP:0000739 | 0.00604005240459 | 0.75 | SDHB SDHAF2 SDHA | Anxiety |
  HP:0006801 | 0.00626129254237 | 0.5 | SDHB SDHA | Hyperactive deep tendon reflexes |
  HP:0100852 | 0.00627960088635 | 0.75 | SDHB SDHAF2 SDHA | Abnormal fear/anxiety-related behavior |
  HP:0002315 | 0.00652537513546 | 0.75 | SDHB SDHAF2 SDHA | Headache |
  HP:0011792 | 0.00652537513546 | 0.75 | SDHB SDHAF2 SDHA | Neoplasm by histology |
  HP:0011153 | 0.00680514289491 | 0.5 | SDHB SDHA | Focal motor seizure |
  WP:WP111 | 0.0071289861505 | 0.5 | SDHB SDHA | Electron Transport Chain (OXPHOS system in mitochondria) |
  HP:0000822 | 0.00803948285574 | 0.75 | SDHB SDHAF2 SDHA | Hypertension |
  GO:0006121 | 0.00811409485621 | 0.5 | SDHA SDHAF2 | mitochondrial electron transport, succinate to ubiquinone |
  GO:0016635 | 0.00811409485621 | 0.5 | SDHA SDHAF4 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor |
  HP:0008047 | 0.00813515731085 | 0.75 | SDHB SDHAF2 SDHA | Abnormality of the vasculature of the eye |
  HP:0000405 | 0.00862487853069 | 0.75 | SDHB SDHAF2 SDHA | Conductive hearing impairment |
  HP:0011452 | 0.00892789465924 | 0.75 | SDHB SDHAF2 SDHA | Functional abnormality of the middle ear |
  HP:0006957 | 0.00920632571228 | 0.5 | SDHB SDHA | Loss of ability to walk |
  HP:0032263 | 0.0112489013074 | 0.75 | SDHB SDHAF2 SDHA | Increased blood pressure |
  HP:0012378 | 0.0116099650177 | 0.75 | SDHB SDHAF2 SDHA | Fatigue |
  HP:0100743 | 0.0119684664945 | 0.5 | SDHB SDHA | Neoplasm of the rectum |
  KEGG:01200 | 0.012776519361 | 0.5 | SDHB SDHA | Carbon metabolism |
  REAC:R-HSA-71406 | 0.013274030298 | 0.5 | SDHB SDHA | Pyruvate metabolism and Citric Acid (TCA) cycle |
  HP:0003117 | 0.0135309297604 | 0.75 | SDHB SDHAF2 SDHA | Abnormal circulating hormone level |
  KEGG:00190 | 0.0136880283161 | 0.5 | SDHB SDHA | Oxidative phosphorylation |
  HP:0002395 | 0.0150911756538 | 0.5 | SDHB SDHA | Lower limb hyperreflexia |
  HP:0001285 | 0.0150911756538 | 0.5 | SDHB SDHA | Spastic tetraparesis |
  WP:WP4396 | 0.0154631487697 | 0.5 | SDHB SDHA | Nonalcoholic fatty liver disease |
  KEGG:05012 | 0.0156041830743 | 0.5 | SDHB SDHA | Parkinson disease |
  HP:0002313 | 0.0159281461127 | 0.5 | SDHB SDHA | Spastic paraparesis |
  GO:0034552 | 0.0162267366884 | 0.5 | SDHAF2 SDHAF4 | respiratory chain complex II assembly |
  GO:0034553 | 0.0162267366884 | 0.5 | SDHAF2 SDHAF4 | mitochondrial respiratory chain complex II assembly |
  HP:0011675 | 0.0164047655465 | 0.75 | SDHB SDHAF2 SDHA | Arrhythmia |
  HP:0008056 | 0.0167125722923 | 0.75 | SDHB SDHAF2 SDHA | Aplasia/Hypoplasia affecting the eye |
  HP:0000525 | 0.0170241838094 | 0.75 | SDHB SDHAF2 SDHA | Abnormality iris morphology |
  HP:0001608 | 0.0173396229329 | 0.75 | SDHB SDHAF2 SDHA | Abnormality of the voice |
  KEGG:04932 | 0.0173825101547 | 0.5 | SDHB SDHA | Non-alcoholic fatty liver disease (NAFLD) |
  HP:0002344 | 0.0176695962482 | 0.5 | SDHB SDHA | Progressive neurologic deterioration |
  HP:0000544 | 0.0176695962482 | 0.5 | SDHB SDHA | External ophthalmoplegia |
  HP:0002017 | 0.0181451162859 | 0.75 | SDHB SDHAF2 SDHA | Nausea and vomiting |
  GO:0098803 | 0.0181462528862 | 0.75 | SDHB SDHAF4 SDHA | respiratory chain complex |
  HP:0030972 | 0.0184741317158 | 0.75 | SDHB SDHAF2 SDHA | Abnormal systemic blood pressure |
  HP:0002505 | 0.01857406376 | 0.5 | SDHB SDHA | Progressive inability to walk |
  GO:0005746 | 0.0189701239271 | 0.75 | SDHB SDHAF4 SDHA | mitochondrial respirasome |
  GO:0006091 | 0.0197812720484 | 1.0 | SDHB SDHAF4 SDHAF2 SDHA | generation of precursor metabolites and energy |
  HP:0030956 | 0.0210685962912 | 0.75 | SDHB SDHAF2 SDHA | Abnormality of cardiovascular system electrophysiology |
  GO:0009060 | 0.0215903857674 | 0.75 | SDHB SDHAF2 SDHA | aerobic respiration |
  HP:0001892 | 0.0223577043802 | 0.75 | SDHB SDHAF2 SDHA | Abnormal bleeding |
  GO:0070469 | 0.0225145500348 | 0.75 | SDHB SDHAF4 SDHA | respirasome |
  KEGG:05010 | 0.0232850911193 | 0.5 | SDHB SDHA | Alzheimer disease |
  HP:0005162 | 0.025534627766 | 0.5 | SDHB SDHA | Left ventricular dysfunction |
  HP:0005214 | 0.0277254502169 | 0.5 | SDHB SDHA | Intestinal obstruction |
  HP:0005150 | 0.0277254502169 | 0.5 | SDHB SDHA | Abnormal atrioventricular conduction |
  HP:0000370 | 0.0278183273244 | 0.75 | SDHB SDHAF2 SDHA | Abnormality of the middle ear |
  HP:0100273 | 0.0288545127028 | 0.5 | SDHB SDHA | Neoplasm of the colon |
  KEGG:05016 | 0.03037774612 | 0.5 | SDHB SDHA | Huntington disease |
  HP:0002385 | 0.0311799098191 | 0.5 | SDHB SDHA | Paraparesis |
  HP:0000553 | 0.0331125866707 | 0.75 | SDHB SDHAF2 SDHA | Abnormal uvea morphology |
  HP:0006380 | 0.0335949626331 | 0.5 | SDHB SDHA | Knee flexion contracture |
  HP:0001337 | 0.0338486678119 | 0.75 | SDHB SDHAF2 SDHA | Tremor |
  HP:0006753 | 0.0360996225593 | 0.5 | SDHB SDHA | Neoplasm of the stomach |
  HP:0004796 | 0.0386938410225 | 0.5 | SDHB SDHA | Gastrointestinal obstruction |
  GO:1990204 | 0.0396936057372 | 0.75 | SDHB SDHAF4 SDHA | oxidoreductase complex |
  HP:0030872 | 0.0400245195282 | 0.5 | SDHB SDHA | Abnormal cardiac ventricular function |
  HP:0003388 | 0.0400245195282 | 0.5 | SDHB SDHA | Easy fatigability |
  GO:0055114 | 0.0422401319933 | 1.0 | SDHB SDHAF4 SDHAF2 SDHA | oxidation-reduction process |
  KEGG:04714 | 0.0427485725169 | 0.5 | SDHB SDHA | Thermogenesis |
  HP:0031466 | 0.0435417391965 | 0.75 | SDHB SDHAF2 SDHA | Impairment in personality functioning |
  REAC:R-HSA-611105 | 0.0435915557177 | 0.5 | SDHB SDHA | Respiratory electron transport |
  GO:0022904 | 0.0439367749778 | 0.75 | SDHB SDHAF2 SDHA | respiratory electron transport chain |
  GO:0022900 | 0.0454154921687 | 0.75 | SDHB SDHAF2 SDHA | electron transport chain |
  HP:0001712 | 0.0455708870915 | 0.5 | SDHB SDHA | Left ventricular hypertrophy |
  HP:0100834 | 0.0470133620262 | 0.5 | SDHB SDHA | Neoplasm of the large intestine |
Edges
Protein 1 | Protein 2 | Score | Precision | Evidence |
---|---|---|---|---|
 SDHA |  SDHB | 0.999 | 0.949           | bioplex (SDHA,SDHB)     bioplex_WMM     Guru     boldt     youn_WMM     fraction     boldt_WMM     |
 SDHAF2 |  SDHA | 0.983 | 0.899           | hein_WMM     bioplex (SDHA)     bioplex_WMM     hein (SDHAF2)     |
 SDHA |  SDHAF4 | 0.939 | 0.85           | bioplex (SDHA)     bioplex_WMM     fraction     |
 SDHB |  SDHAF4 | 0.009 | 0.091           | bioplex_WMM     WMM_only     |
 SDHAF2 |  SDHAF4 | 0.008 | 0.091           | bioplex_WMM     WMM_only     |
 SDHAF2 |  SDHB | 0.008 | 0.024           | bioplex_WMM     WMM_only     |
Images
Click to enlarge

Complex HuMAP2_04642 has an average edge precision of 0.484 which is ranked 2599 out of all 6965 complexes.
Related Complexes
Genename | Complexes |
---|---|
SDHAF2 | HuMAP2_03232 HuMAP2_04642 HuMAP2_04832 HuMAP2_05446 |
SDHB | HuMAP2_03232 HuMAP2_04642 |
SDHA | HuMAP2_03232 HuMAP2_04642 HuMAP2_04832 HuMAP2_05446 |
SDHAF4 | HuMAP2_04609 HuMAP2_04642 HuMAP2_04832 HuMAP2_05446 |